Category Archives: Cannabis Legalization

1933 Industries Executes Licensing Agreement with PLUGplay and Prepares for Nevada-Wide Launch of Unique Vaporizer Pod System

1933 Industries Executes Licensing Agreement with PLUGplay and Prepares for Nevada-Wide Launch of Unique Vaporizer Pod System

1933 Industries Inc. (TGIF.CN) (TGIFF), a vertically integrated cannabis consumer packaged goods company, is pleased to announce a Licensing Agreement with California -based PLUGplay, a manufacturer of cannabis vaporizer cartridges with proprietary magnetic hardware, for a 12-month term.

PLUGplay’s premium distillate oil cartridges feature sleek, high quality magnetic pods and long-lasting batteries. The California brand has made a name not only for its custom hardware but for its dedication to crafting premium distillate concentrates. Under the terms of the Agreement, the Company’s subsidiary, Alternative Medicine Association (AMA) will manufacture distillate and vape pens under the PLUGplay brand, for distribution to dispensaries across Nevada .

PLUGplay’s premium oil and advanced vaporizer technology provides a subtle and convenient experience.  “Our mission was to manufacture a best in class vape product that would stand out among the rest,” said Mr. Jon Lee , VP of Business Development at PLUGplay.

He added, “We are extraction artists committed to crafting premium distillate concentrates and we recognized the need in the market for hardware that would provide consumers discreet and easy access to wellness. We believe that vape oils are becoming the optimal means to introduce cannabis to a consumer that is looking for natural alternatives with reliable cannabis oils and batteries for a unique experience. The combination of superior oils and long-lasting batteries makes a winning combination.”

1933 Industries CEO, Mr. Chris Rebentisch remarked, “PLUGplay only partners with cultivators and processors that meet extremely high standards in cultivation and manufacturing and we share the same vision. We strictly follow regulations and standards outlined by the State of Nevada and offer our partners an advanced cultivation facility, superior strains, precise extraction services, consistent products and distribution in the state. We are continuing to attract innovators with established reputations in this field to our house of brands.”

About PLUGplay
Deeply rooted in medicinal cannabis, the founders of PLUGplay have been involved in the industry for over a decade in cultivation, oil extraction and concentrates, bringing their positive experiences surrounding cannabis to the masses. PLUGplay partners with cannabis farms that meet state high standards in their grow. Only buds from pesticide-free environments are allowed for processing. Plug cartridges provide a glimpse into modern cannabis vapes with a variety of products crafted to meet the needs of the diverse cannabis community. Play vape batteries deliver a unique mechanism for cannabis vaporizing.

About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada . Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets.

With the goal of delivering natural wellness, our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Birdhouse Skateboards™, Blonde™ Cannabis, Denver Dab Co., Gotti’s Gold, Kurupt Moonrocks, OG DNA Genetics, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
http://www.cannahemp.com
https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
http://www.cannahempx.com
https://herb.co/learn/best-cannabis-products/

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Cision

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/1933-industries-executes-licensing-agreement-with-plugplay-and-prepares-for-nevada-wide-launch-of-unique-vaporizer-pod-system-300921471.html

SOURCE 1933 Industries Inc.

View photos

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2019/19/c2721.html

Published at Thu, 19 Sep 2019 12:43:24 +0000

Industry Leading Cannabis Equipment Leasing Company, Xtraction Services (CSE:XS), To Debut On The CSE Today

Industry Leading Cannabis Equipment Leasing Company, Xtraction Services (CSE:XS), To Debut On The CSE Today

Demand for cannabis oils, especially high cannabidiol (CBD) oil, has increased significantly and this is a trend we expect to continue as researchers learn more about the therapeutic benefit cannabinoids provide. During the last year, we have noticed a significant increase in the number of companies that are focused on the cannabis oil opportunity. Although many of these businesses have grandiose plans as it relates to the cannabis oil market, an overwhelming majority of these companies do not have the capital that is needed to construct a state-of-the-art extraction facility. Xtraction Services represents a differentiated opportunity when it comes to cannabis concentrates and we are favorable on the approach the team has taken to this burgeoning vertical of the cannabis industry.

Click Here To Receive An Investor Presentation and Stay Up To Date On Xtraction Services (CSE:XS)

Xtraction Services has built a business model that is centered around helping extraction companies and by providing equipment leasing solutions for up to 100% of the new or used equipment that is required by each respective client. The company’s mission is to support their clients throughout the entire installation and extraction process.

Today, Xtraction Services (CSE:XS) completed a go-public transaction on the Canadian Stock Exchange (CSE) and commenced trading on September 13 under the symbol, XS. The company represents a differentiated growth opportunity that is levered to one of the most exciting verticals of the cannabis industry.

When you look at the Xtraction Services website (https://www.xtractnow.com), you will notice that the company has received raving reviews from several leading US cannabis concentrate companies. In a world where quality customer service is difficult to find, we are favorable on this approach due to the relationship that the company fosters with each client.

A High-Margin Growth Story to be Watching

Xtraction Services has a high-margin business model where customers receive processing equipment following a down payment and where the company is compensated through lease and royalty/service payments. The management team has a proven track record of success and relationships with key equipment manufacturers, which provides Xtraction Services with an important competitive advantage.

During the last year, Xtraction Services has seen a significant increase in the number of customers as well as the size of the transactions being closed. The company currently has a backlog of projects and we are bullish on the growth prospects associated with this pipeline of new business. Xtraction Services has an established client base and is already generating significant revenues.

So far, the company has established the following relationships:

  • Oregon – Completed the sale of CBD manufacturer post-processing equipment
  • California – Completed the sale of THC manufacturer post-processing equipment
  • Kentucky – Signed a 30 month lease (royalty) hemp manufacturer (2) production lines
  • Kentucky – Signed a 24 month lease (royalty) hemp manufacturer full production line
  • South Carolina – signed a 12 month and a 14 month hemp manufacturer extraction equipment lease

When it comes to the current pipeline, Xtraction Services has more opportunities than it can service. These represent a robust emerging opportunity and we are bullish on the growth prospects associated with the pipeline. Additionally, due to the nature of the business XS is able to operate across the U.S. giving them a massive total addressable market serving both THC and CBD customers as well as start-ups to more mature businesses. Over the next year, we anticipate that the company will close several new deals and expect for this to be a catalyst for continued growth.

In the Early Innings of a Major Growth Cycle

Over the next year, we expect to see Xtraction Services report strong growth as it continues to deliver state-of-the-art processing equipment to its roster of clients. The company offers a wide variety of products to satisfy consumer demand and we are favorable on this aspect of the story. During the last year, we have seen a significant increase in these types of cannabis concentrate products and this is a trend that will benefit companies like Xtraction Services. By offering a robust product pipeline, the company will appeal to a wide variety of clients who are trying to produce these premium cannabis concentrates at scale.

Xtraction Services offers leasing options that provide short payback periods and high initial rates of return (IRR). Through leasing or sale-leasebacks, the company is able to generate an IRR that is greater than 50% and we find this to be significant. The length of these contracts varies between 1 and 3 years and we are favorable on this structure.

The current pipeline includes a combination of lease and lease/royalty hybrid structures and we are favorable on the flexibility that is provided by the company. Lease financing provides a fixed payment to the company while a royalty payment allows the company to benefit from the additional upside of what is produced by clients.

Through a sale-leaseback transaction, customers who already own their equipment can benefit by working with Xtraction Services. With this transaction, the customer continues to use the equipment and pays a fixed monthly lease payment to Xtraction Services. At maturity, the company has the option to re-sell the equipment to the customer and we are favorable on this.

When it comes to determining what purchasing solution to offer each potential client, the relationship that the company has with the prospect plays an important role in the process. We believe that the management team has done a great job when it comes to identifying strategic partners and has secured royalty deals with the right types of clients.

An Emerging Opportunity to be Watching

When looking at Xtraction Services, we see a differentiated opportunity that has significant growth prospects. We are favorable on the vertical that the business is focused on and will monitor how the management team continues to drive the story forward. With the markets that Xtraction Services is levered to and focused on, we find the risk-reward scenario to be attractive and this is an opportunity to be watching.

Going forward, we expect to see Xtraction Services gain significant awareness following the completion of a go-public transaction. The company can use its stock as a currency when it comes to the expansion opportunity and we find this to be significant. We believe that Xtraction Services is an attractive growth story that is in the early innings of a major growth cycle.

Although the last few months have been rough on the cannabis sector, we believe that the sector has been trending higher and coming off its recent lows. Xtraction Services could be well positioned to benefit from a timing standpoint, and we are going to closely follow this new listing.

To learn more about Xtraction Services, please reach out to Support@technical420.com to be added to our distribution list.

Pursuant to an agreement between StoneBridge Partners LLC and Xtraction Services (XS) we have been hired for a period of 180 days beginning September 11, 2019 and ending March 11, 2020 to publicly disseminate information about (XS) including on the Website and other media including Facebook and Twitter. We are being paid $0 per month (XS) for or were paid “92,045” shares of restricted common shares. We own zero shares of (XS), which we purchased in the open market. We plan to sell the “ZERO” shares of (XS) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (XS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Fri, 13 Sep 2019 11:36:26 +0000

Innovative Industrial Properties Declares Third Quarter 2019 Dividends

Innovative Industrial Properties Declares Third Quarter 2019 Dividends

Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a third quarter 2019 dividend of $0.78 per share of common stock, representing a 30% increase over IIP’s second quarter 2019 dividend of $0.60 per share of common stock, and an approximately 123% increase over IIP’s third quarter 2018 dividend of $0.35 per share of common stock. The dividend is equivalent to an annualized dividend of $3.12 per common share, and is the fifth dividend increase since the Company completed its initial public offering in December 2016.

Additionally, IIP announced today that its board of directors has declared a regular quarterly dividend of $0.5625 per share of IIP’s 9.00% Series A Cumulative Redeemable Preferred Stock.

The dividends are payable on October 15, 2019 to stockholders of record at the close of business on September 30, 2019.

About Innovative Industrial Properties

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017. Additional information is available at www.innovativeindustrialproperties.com.

This press release contains statements that IIP believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as we “expect,” “intend,” “plan,” “estimate,” “anticipate,” “believe” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright Business Wire 2019

Source: Business Wire (September 13, 2019 – 6:30 AM EDT)

News by QuoteMedia
www.quotemedia.com

Published at Fri, 13 Sep 2019 11:52:03 +0000

Next Green Wave Rolls Out Premium Exotic Flower Line In Collaboration With Iconic “NoJumper”

Next Green Wave Rolls Out Premium Exotic Flower Line In Collaboration With Iconic “NoJumper”

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”) is pleased to announce that it has partnered with the iconic “NoJumper” brand and host “Adam 22” to roll out its latest premium exotic flower strains. The products will be featured on a monthly basis through NoJumper’s Podcast with 45 million viewers per stream and Next Green Wave’s brand house SDC. The flower will be available at leading Los Angeles and San Diego dispensaries, including March and Ash within two weeks.

Cannot view this image? Visit: https://www.thethcreport.com/wp-content/uploads/2019/09/vmFv8L.jpg

To view an enhanced version of this graphic, please visit:

https://orders.newsfilecorp.com/files/6127/47754_5307a0c004606bd3_001full.jpg

With over 45 million views per stream, NoJumper has become an influential hub to launch upcoming musicians, artists and acts on its weekly celebrity-spot podcast show. NoJumper clothing and merchandise are currently sold at their Melrose store in Hollywood and Zumiez clothing stores nationwide.

This strategic partnership will enable Next Green Wave to gain access to major cultural events such as music festivals and leverage its many influencer and celebrity social channels that directly reach the Company’s target consumer demographic.

“We are really thrilled about the collaboration with NoJumper as it demonstrates we are ready to permeate major consumer markets and are delivering premium craft product that is being sought out for its quality and value, which is currently lacking in the legal market in California.” -Michael Jennings, CEO.

“Recently we did a test pop-up shop and meet and greet with Adam 22 in Chicago and to our surprise over 1000 people attended, some even slept in line overnight to be first inside. That is when we knew this brand has real reach and a powerful voice of influence.” – Ryan Lange CMO

In addition, the Company would like to announce that it has completed a Non-Brokered financing of 2,000,000 units (the “Units”) at a price of $0.25 per Unit for gross proceeds of $500,000 (the “Financing”). Each unit will be comprised of one common share of Next Green Wave (a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder there of to acquire one Share at a price of $0.35 for a period of 24 month, subject to an acceleration provision whereby in the event that at any time after the expiry of the statutory hold period, the Shares trade at $0.50 or higher on the Canadian Securities Exchange for a period of 10 consecutive days, the Company shall have the right to accelerate the expiry date of the Warrants to the date that is 30 days after the Company issues a news release announcing that it has elected to exercise the acceleration right.

There were no finders’ fees incurred in connection with the Financing.

The Company intends to use the proceeds from the Financing to accelerate inventory purchase requirements and marketing initiatives for our SDC products, brands, and operations.

NoJumper

Adam John Grandmaison, better known as Adam22, is an American podcast host, internet personality, and record executive. He is best known for being the creator and host of pop culture and hip hop-oriented podcast NoJumper. NoJumper has grown into a Mega Brand that started in a small BMX stop on Melrose Avenue next to the famed BAIT store. It is there that they started interviewing professional athletes and music celebrities for their podcast that quickly grew to over a million followers on Instagram. The team is well known for breaking new Hip Hop acts and introducing major artists on their channel.

About Next Green Wave

NGW is a fully integrated premium cannabis producer with 8 legacy brands and over 45 products through its subsidiary WEARESDC. Based in Coalinga, California the company owns and operates a state-of-the-art cultivation facility and is currently expanding operations on the cannabis zoned property it is situated on. NGW has a seed library of over 120 strains which include multiple award-winning genetics and cultivars and is developing its nursery cloning operations with bio-tech leader Intrexon. The company also has an investment in OMG, a Colombian cannabis operator with over 8,000 access points of sale. To find out more visit us at www.nextgreenwave.com or follow us on TwitterInstagram, or LinkedIn.

On behalf of the board,

Michael Jennings, CEO

Next Green Wave Holdings Inc.

For more information regarding Next Green Wave, contact:

Caroline Klukowski

VP Corp. Development

Tel: +1 (778) 589-2848

IR@nextgreenwave.com

Next Green Wave Forward Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the risk factors included in the preliminary prospectus, including without limitation dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of Tranche 1 and Tranche 2 of the Notes; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. Readers are encouraged to the review the section titled “Risk Factors” in NGW’s prospectus. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47754

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Thu, 12 Sep 2019 13:17:35 +0000

Tilray, Inc. and Privateer Holdings, Inc. Sign Definitive Agreement to Extend Lock-up and Provide for Orderly Distribution of 75 Million Tilray Shares Held by Privateer

Tilray, Inc. and Privateer Holdings, Inc. Sign Definitive Agreement to Extend Lock-up and Provide for Orderly Distribution of 75 Million Tilray Shares Held by Privateer

Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that it has signed a definitive merger agreement with its largest stockholder Privateer Holdings, Inc. (“Privateer”) for a transaction that will extend the lock-up on and provide for the issuance of up to 75 million Tilray shares to Privateer’s equity holders (and the cancellation of the 75 million shares currently owned by Privateer). These shares currently represent 77 percent of Tilray’s total shares outstanding. Tilray and Privateer previously announced the signing of a non-binding Letter of Intent for this transaction on June 10, 2019.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190909005492/en/

Under the terms of the definitive agreement, the parties will effect a downstream merger of Privateer with and into a wholly-owned subsidiary of Tilray, with the Tilray subsidiary surviving the merger, and the issuance by Tilray to Privateer equity holders of newly issued and registered shares of Tilray common stock and options to purchase shares of Tilray common stock in an aggregate amount equal to the number of Tilray common shares currently held by Privateer. As set forth in the definitive agreement, at its sole election (to be made prior to closing), Tilray may pay a portion of the merger consideration in cash in lieu of issuing an equivalent number of shares of Tilray. All Tilray shares held by Privateer and all outstanding Privateer stock will be cancelled upon consummation of the merger.

Tilray was originally incubated and financed by Privateer as one of its wholly-owned operating subsidiaries before closing a Series A round of capital in February 2018 and then becoming the first cannabis producer to complete an Initial Public Offering (IPO) on a major U.S. stock exchange in July 2018. Earlier this year, Privateer distributed its ownership of its three other operating subsidiaries unrelated to Tilray directly to Privateer stockholders, leaving no material assets in Privateer other than the 75 million shares it currently holds in Tilray.

Pursuant to the terms of the definitive merger agreement, each Privateer equity holder who receives the shares of Tilray stock in the merger will be subject to a lock-up allowing for the sale of such shares only under certain circumstances over a two-year period. During the first year following the closing of the merger, shares will be released only pursuant to certain offerings or sales arranged by and at the discretion of Tilray. At the end of the first year, to the extent not already released as a result of any cash paid at closing and/or the aforementioned offerings or sales, 50 percent of the total shares subject to the lock-up will be released. Over the course of the second year following closing, the remaining shares will be subject to a staggered release in equal quarterly increments.

Mark Castaneda, Chief Financial Officer of Tilray, said: “We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to having their investors as part of our stockholder base. We believe this transaction will give Tilray greater control and operating flexibility, while allowing us to effectively manage our public float.”

Michael Blue, Managing Partner of Privateer, said: “We are pleased to sign this agreement with Tilray, which we believe will maximize overall returns for our visionary investors in a tax-efficient manner while giving Tilray the operating flexibility it needs to continue to be a leader in the rapidly emerging global cannabis industry.”

In accordance with the terms of the transaction, the 16.7 million shares of Tilray Class 1 Common Stock (which have ten (10) votes per share) will be issued to Brendan Kennedy, Christian Groh and Michael Blue, the cofounders of Privateer, as part of their proportionate share of the merger consideration, with the remainder of the stock merger consideration being Tilray Class 2 Common Stock (which have one (1) vote per share). The merger agreement provides that $125 million worth of Tilray Class 2 Common Stock will be held in escrow for 18 months following the closing of the transaction to secure any potential indemnification claims, with the initial 50 percent of such escrow being withheld from all Privateer stockholders on a pro rata basis, and the remaining 50 percent coming solely from the Privateer cofounders.

The transaction has been unanimously approved by each of the Special Committee of Tilray’s Board of Directors (comprised of independent directors) and Privateer’s Board of Directors. The merger and the transactions contemplated in connection therewith will be consummated only if all conditions to closing set forth in the merger agreement are satisfied, including the requisite approval of the merger by the stockholders of Privateer and Tilray. Both parties intend to complete the transaction as expeditiously as possible.

About Tilray®
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in thirteen countries spanning five continents.

About Privateer Holdings, Inc.
Privateer Holdings is the world’s first private equity firm to invest exclusively in legal cannabis. The Privateer Holdings team has raised $200 million to invest in cannabis brands. Learn more at www.privateerholdings.com.

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, including statements in respect to Tilray and the consummation of the merger. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment and future approvals and permits. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Please see the heading “Risk Factors” in Tilray’s Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission (“SEC”) and Canadian securities regulators on August 13, 2019, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Tilray does not undertake and specifically declines any obligation to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.

Important Merger Information and Additional Information
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, Tilray will file relevant materials with the SEC. Tilray will file a Registration Statement on Form S-4 that includes a proxy statement of Tilray and which also constitutes a prospectus of Tilray. Tilray and Privateer will mail the final proxy statement/prospectus to the respective stockholders of Tilray and Privateer. Investors are urged to read the proxy statement/prospectus regarding the proposed transaction when it becomes available, because it will contain important information. The proxy statement/prospectus and other relevant documents that have been or will be filed by Tilray with the SEC are or will be available free of charge at the SEC’s website, www.sec.gov, or by directing a request when such a filing is made to Tilray Investor Relations at ICR, 685 Third Avenue, Second Floor, New York, NY 10017, attention: Katie Turner.

Tilray and certain of its directors, executive officers and other members of management and employees may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Tilray is set forth in its definitive proxy statement which was filed with the SEC on April 15, 2019 and can be obtained free of charge from the sources listed above. Investors may obtain additional information regarding the interests of such participants by reading the proxy statement/prospectus Tilray will file with the SEC when it becomes available.

Copyright Business Wire 2019

Published at Mon, 09 Sep 2019 12:02:02 +0000

Jushi Holdings Inc. Unveils Two New BEYOND / HELLO™ Medical Marijuana Dispensaries In Pennsylvania

Jushi Holdings Inc. Unveils Two New BEYOND / HELLO™ Medical Marijuana Dispensaries In Pennsylvania

BEYOND / HELLOa premier retail chain owned by Jushi Holdings Inc. (“Jushi” or the “Company”)(NEO: JUSH.B), a leading company focused on bringing only the best, personalized marijuana treatments and products to customers, today announced BEYOND / HELLO has opened two additional retail locations. Located at 1137 Moosic Street in Scranton and 416 Main Street in Johnstown, PA, both dispensaries opened after receiving approval from the Pennsylvania Department of Health.

“As we strategically expand our footprint across the Commonwealth, our goal is to bring more patients access to state-approved medicinal treatments that work for them,” said BEYOND / HELLO President Blythe Huestis. “With the opening of our Scranton and Johnstown locations, we are providing patients and caregivers increased access to some of the best medicinal treatments and professional expertise available. In addition, these openings will create roughly 50 new, livable-wage jobs in the communities they serve.”

BEYOND / HELLO Scranton and BEYOND / HELLO Johnstown will carry a wide array of medical marijuana products, including dry leaf, oils and oil cartridges, concentrates, pills, capsules, tinctures, topicals and various ancillary products. A licensed pharmacist, along with seasoned, trained staff, will be on-site to dispense products, answer questions and provide service to patients and caregivers. As the Commonwealth expands its program, BEYOND / HELLO will continue to make state-approved products available to patients.

“With the latest openings, and more retail locations expected to launch later this year, BEYOND / HELLO has become a vital part of these Pennsylvania communities and an important brand for our expanding portfolio,” said Jushi CEO and Chairman, Jim Cacioppo. “We are proud to provide the communities of Scranton and Johnstown access to superior cannabis products.”

The new BEYOND / HELLO locations added this summer, along with more stores expected to open by the end of the year, will bring an estimated 300 new jobs across the Commonwealth by the end of 2019.  BEYOND / HELLO targets hiring personnel within local communities and has a strong track record of promoting employees from within the company. It is the BEYOND / HELLO ethos to create a culture that always places patients and caregivers first.

With these stores, there is one BEYOND / HELLO location in Bristol, Johnstown and Scranton and two in Philadelphia, for a total of five locations in the Commonwealth.

For more information on BEYOND / HELLO, visit https://beyond-hello.com and on Instagram at @beyond_hello_dispensary.

About BEYOND / HELLOTM
BEYOND / HELLOTM, a premier retail chain owned by Jushi Holdings Inc., is a leading dispensary brand focused on bringing personalized service and individualized experiences to customers beyond the first visit and beyond the first hello. Led by a team of industry and medical experts, BEYOND / HELLOTM brings trusted, personalized marijuana treatments to customers with compassion and professionalism. For more information, please visit https://beyond-hello.com and on Instagram at @beyond_hello_dispensary.

About Jushi Holdings Inc.
Jushi is a globally-focused cannabis and hemp company led by an industry leading management team. In the United States Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed work-outs and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information please visit www.jushico.com or our social media channels; InstagramFacebookTwitter and LinkedIn.

Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, information concerning the expectations regarding Jushi, or the ability of Jushi to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability of Jushi to successfully achieve business objectives, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; and compliance with extensive government regulation, as well as other risks and uncertainties which are more fully described in the Company’s Filing Statement dated May 31, 2019 and other filings with securities and regulatory authorities which are available at www.sedar.com.  Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Cision

 View original content:http://www.prnewswire.com/news-releases/jushi-holdings-inc-unveils-two-new-beyond–hello-medical-marijuana-dispensaries-in-pennsylvania-300914110.html

SOURCE Jushi Holdings Inc.

Published at Mon, 09 Sep 2019 14:32:25 +0000

Chemesis Is Quietly Putting Key Pieces In Place To Capitalize On The U.S. Cannabis Market

Chemesis Is Quietly Putting Key Pieces In Place To Capitalize On The U.S. Cannabis Market

Last month, we published an update on Chemesis International Inc. (CSI.CN) (CADMF) which has been laser focused on the US cannabis market and this is an opportunity to put on your radar.

2019 has been a banner year for the US cannabis company and we are favorable on the way the story has evolved so far this year. Through a series of acquisitions, Chemesis has been able to position itself in strategic cannabis markets and we are favorable on this aspect of the story. Over the next year, we expect the company to start to report strong revenue growth and this is a trend that is expected to become more significant in 2020.

Today, we have published an update on Chemesis International and this comes after the company reported a major development. During the last few months, the company has been trending lower with the rest of the cannabis sector and we believe that the market may be missing out on something big.

Acquires Controlling Ownership Interest in a U.S. Multi-State Operator

Chemesis is one of the few cannabis companies to be highly focused on the opportunity in Puerto Rico and we believe that the market does not assign much value to this side of the business. A few weeks ago, Chemesis reported to have enhanced its leverage to this burgeoning cannabis market through the acquisition of a controlling interest in GSRX Industries Inc. (GSRX). Earlier this year, the company made its initial investment in GSRX and we are favorable on the way these assets complement the existing business.

Over the next year, we expect GSRX to play a key role in the success of Chemesis and will monitor how the combined company is able to increase market share in strategic cannabis markets. As a result of the acquisition, GSRX is a subsidiary of Chemesis and its assets (including the 7,291,874 Chemesis common shares that it owns) will be consolidated with Chemesis on a going-forward basis.

One of the reasons we are bullish on the transaction is due to the way it expands the Chemesis operation. Through the acquisition of GSRX, the combined company is a fully vertically integrated, multi-state operator with assets in six states (California, Tennessee, Arizona, Michigan, Texas, and Puerto Rico). GSRX’s asset portfolio includes:

  • Five operational dispensaries in Puerto Rico, which operate under Green Spirit Rx brand
  • Five additional pre-qualified dispensaries in Puerto Rico that are in various stages of development and construction.
  • A fully licensed cannabis distribution center in Point Arena, California that is expected to service over 400 dispensaries in Northern & Central California.
  • The Green Room, a boutique dispensary located in Point Arena California that has been owned and operated since April 2018.
  • The Green Room, a 4,500 sq. ft. large scale dispensary located in Palm Springs, California. The dispensary is currently undergoing renovations and expects to be open by the first quarter of 2020.
  • Retail CBD stores in Texas and Tennessee, with products such as creams, balms, tinctures, pet products, face masks, vape pens, and soft gels.

Another reason we are bullish on the transaction is due to the value that each company brings to the table. Chemesis has extensive manufacturing, extraction, distribution, and processing capabilities, which complement GSRX’s ability to operate cannabis dispensaries. Chemesis intends to leverage its facilities and processing capabilities to manufacture finished goods for GSRX’s operating dispensaries, with the aim of further increasing margins and operational efficiencies.

A Multi-Faceted US Growth Story

Following the completion of the GSRX transaction, Chemesis is better positioned to capitalize on the US cannabis industry. When this development was reported, the company also announced the completion of a $1.4 million non-brokered private placement and we expect the proceeds to be put to work in ways that advance this current business.

Going forward, Chemesis is well positioned to record strong growth and we are especially favorable on the leverage to the California and the Michican markets. These recreational cannabis markets represent significant growth verticals for the overall business and believe that the market underappreciates this aspect of the business.

During the last year, Chemesis has been executing on all cylinders and is led by a management team that has had its finger on the pulse of the industry. From CBD to THC, the company is focused on several of the most attractive verticals of the cannabis industry and we find this to be significant. Chemesis represents a multi-faceted growth story that is trading at a discount when compared to its peers.

Chemesis has come off its recent lows and momentum has been trending higher. This is an opportunity that is flying under the radar and one that we are excited about. To learn more about Chemesis, please reach out to support@technical420.com and we will add you to our distribution list.

Pursuant to an agreement between StoneBridge Partners LLC and Chemesis International we have been hired for a period of 365 days beginning July 15, 2018 and ending July 15, 2019 to publicly disseminate information about (CSI) including on the Website and other media including Facebook and Twitter. We are being paid $5,000 per month for a period of 3 months. We own zero shares of (CSI), which we purchased in the open market. We plan to sell the “ZERO” shares of (CSI) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (CSI) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. This contract has been renewed for a period of 180 days beginning on August 2, 2019 and ending on February 2, 2020.

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Fri, 06 Sep 2019 11:28:46 +0000

Chemesis International Inc. Provides Update on Rapid Dose

Chemesis International Inc. Provides Update on Rapid Dose

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has completed the installation, permitting, and testing phase of its QuickStriporal thin strip production equipment. The Company has completed the previously announced commercialization strategy, and has begun accepting orders for QuickStrip for immediate distribution across Puerto Rico and the United States.

Since receiving Gold Vendor Status from Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) Chemesis has continued to work diligently to ensure the QuickStrip go to market strategy is done effectively and efficiently. The Company expects to see a consistent increase in revenue as consumers move to a more Quick, Convenient, Precise, and Discrete™ method of consumption.

“Our partnership with RDT brings an incredible amount of potential growth for Chemesis,” said Chief Executive Officer of Chemesis, Edgar Montero. “The partnership gives Chemesis access to a large market of consumers that are looking for alternatives that provide a No Smoke, No Smell, No Stigma™ administration of THC or CBD.”

On Behalf of The Board of Directors
Edgar Montero
CEO and Director

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia.

The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.

Chemesis has facilities in both Puerto Rico and California and is in the process of constructing a GMP certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft2 of cultivation, and 35,000 ft2 of manufacturing floor space. The Company is positioned to win additional licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.

Social Media:

Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX

About Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT’s QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT’s service-based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.

For more information, visit: www.rapid-dose.com

For inquiries please contact:
Ian Fodie, CFO Ali Mahdavi, Managing Director
Rapid Dose Therapeutics Corp. Spinnaker Capital Markets Inc.
ifodie@rapid-dose.com am@spinnakercmi.com
Office (416) 477-1052 Office (416) 962-3300

Social Media
RapidDoseTherapeutics.linkedin
RapidDoseTherapeutics.twitter
RapidDoseTherapeutics.facebook
QuickStrip.instagram

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

Primary Logo

Source: GlobeNewswire (September 4, 2019 – 1:44 PM EDT)

News by QuoteMedia
www.quotemedia.com

Published at Wed, 04 Sep 2019 17:50:14 +0000

Sundial Growers Announces Up To $140 Million Corporate Credit Facilities with ATB Financial and Bank of Montreal

Sundial Growers Announces Up To $140 Million Corporate Credit Facilities with ATB Financial and Bank of Montreal

Sundial Growers Inc. (Nasdaq:SNDL) (“Sundial” or the “Company”) announced today that it has entered into a syndicated credit agreement (the “Credit Agreement”) with ATB Financial (“ATB”) and Bank of Montreal (“BMO”) as co-lead arrangers and joint bookrunners (collectively the “Lenders”) with ATB as administrative agent and BMO as syndication agent. Under the terms of the Credit Agreement, the Lenders will provide Sundial with an initial C$90 million of secured debt facilities (collectively, the “Credit Facility”), comprised of a C$84 million senior secured term credit facility and a C$6 million senior secured revolving operating facility. Under the Credit Agreement, Sundial also has the right to an additional facility to a maximum of C$50 million (for a total of C$140 million) to finance the construction of additional buildings at its Canadian production facilities, subject to the consent of the Lenders and satisfaction of certain other conditions.

Sundial Growers (CNW Group/Sundial Growers Inc.)

Upon closing of the Credit Agreement, approximately C$48 million of the Credit Facility was drawn to refinance amounts owing under the Company’s prior debt facility with ATB. The term of the Credit Facility is two years. The Credit Facility is secured by all of Sundial’s Canadian assets, including its production facilities comprised of the flagship production facility located in Olds, Alberta, the Rocky View, Alberta facility and the purpose-built facility currently being constructed in Merritt, British Columbia.

“With the completion of the Credit Facility, including the C$50 million accordion feature, and the proceeds from our recent IPO, we are well capitalized to execute our business plan in both Canada and the UK/Europe. This is a significant step for our business and will allow Sundial to focus on what we do best which is to proudly craft pioneering cannabis brands to Heal, Help and Play,” said Torsten Kuenzlen, Chief Executive Officer of Sundial.

“The ongoing commitment made by our partners, both of which are leading financial institutions in Canada, demonstrates continued confidence in Sundial’s business and the anticipated cash flow generating ability of our Sundial platform”, added Mr. Kuenzlen.

For more information about Sundial, visit www.sndlgroup.com and follow us on Twitter @SundialCannabis, Instagram @SundialCannabis, LinkedIn @SundialCannabis and Facebook @SundialCommunity.

ABOUT SUNDIAL GROWERS INC.

Sundial proudly crafts pioneering cannabis brands to Heal, Help and Play:

  • Heal – cannabis products used as prescription medicine
  • Help – cannabis products that strive to promote health and wellness through CBD
  • Play – cannabis products to enhance social, spiritual and recreational occasions

Sundial is a global cannabis company with facilities in Canada and the United Kingdom, providing high-quality, consistent products consumers can trust.

In Canada, we grow ‘craft-at-scale’ cannabis using purpose-built modular facilities and award-winning genetics. Sundial’s flagship production facility is located in Olds, Alberta with a second facility in Rocky View, Alberta. We have commenced construction of our next purpose-built facility in Merritt, British Columbia.

In the United Kingdom, we grow high-quality traceable plants, including hemp, ornamental flowers and edible herbs, in over 1.5 million square feet of state-of-the-art environmentally friendly, indoor facilities. Bridge Farm has three facilities in Spalding, with another currently under construction.

We employ nearly 1,000 employees globally, full-time and seasonal, which brings economic benefits to the local communities in which we operate.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release include, but are not limited to, the potential expansion plans of the Company in Canada and the UK. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/sundial-growers-announces-up-to-140-million-corporate-credit-facilities-with-atb-financial-and-bank-of-montreal-300909638.html

SOURCE Sundial Growers Inc.

Published at Fri, 30 Aug 2019 12:11:24 +0000

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed its over-subscribed, non-brokered private placement (the “Offering”) of units (the “Units”) at a price of C$0.25 per Unit for total gross proceeds of C$3,457,500.

Each Unit consists of one common share in the capital of the Company (a “Share”) and one Share purchase warrant (a “Warrant”). Each Warrant entitles the holder to acquire one Share at a price of C$0.35 until August 29, 2021.

“We are very pleased to have closed this financing, which saw major demand from the market and was heavily oversubscribed. This is an exciting time of growth for the company and this capital will allow us to invest in and scale our business effectively,” stated Dr. Patricio Stocker, Chief Executive Officer. “This financing included further investment from our founding shareholders, strategic investors, and participation by members of management and the board.”

The net proceeds of the Offering will be used to further expand the Company’s Colombian cultivation and extraction facilities as well as for working capital and general corporate purposes. The Company expects to close a second tranche of the Offering in September.

PowerOne Capital Markets Limited acted as finder in connection with the Offering. A 7% cash finder’s fee was paid together with the issuance of finder warrants (the “Finder Warrants”) equal to 7% of the Units placed. Each Finder Warrant entitles the holder to acquire one Unit for $0.25 until August 29, 2021.

About Blueberries Medical Corp.
Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact:

Camilo Villalba, Chief Operating Officer
cvillalba@blueberriesmed.com
Tel: +57 (313) 483 0131

Ian Atacan, Chief Financial Officer
iatacan@blueberriesmed.com
Tel: +1 (416) 562 3220

Jessika Angarita, Pacta Relations
angarita@pactarelations.com
Tel: +1 (305) 877 4710

Cautionary Note Regarding Forward-Looking Information
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate, among other things, to: the completion of the second tranche of the Offering, the proposed use of the net proceeds from the Offering, and the Company’s objectives, goals, and future plans.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Additional information regarding the Company, and other risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s Listing Statement dated January 31, 2019 filed on its issuer profile on SEDAR at www.sedar.com.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Primary Logo

Published at Fri, 30 Aug 2019 12:17:13 +0000